Discontinued — last reported Q4 '19
Thermo Fisher Scientific Accrued Payroll and Related Expenses increased by 5.9% to $2.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from $1.99B to $2.00B. Over 5 years (FY 2020 to FY 2025), Accrued Payroll and Related Expenses shows relatively stable performance with a 0.8% CAGR.
An increase often correlates with headcount growth or the accrual of performance bonuses, while a decrease may reflect seasonal payroll timing differences.
This captures the liability for wages, salaries, bonuses, and benefits earned by employees but not yet disbursed as of t...
Standard across all labor-intensive industries, though timing varies based on specific payroll processing schedules.
accrued_payroll_and_related_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.49B | $1.82B | $2.43B | $1.63B | $1.72B | $1.86B | $0.10 | $1.31B | $1.31B | $1.46B | $0.10 | $1.31B | $1.50B | $1.82B | $1.99B | $1.42B | $1.52B | $1.88B | $2.00B |
| QoQ Change | — | +21.7% | +33.6% | -32.7% | +5.4% | +8.2% | -100.0% | >999% | +0.2% | +11.5% | -100.0% | >999% | +13.8% | +21.9% | +9.1% | -28.6% | +7.0% | +24.1% | +5.9% |
| YoY Change | — | — | — | — | +15.4% | +2.6% | -100.0% | -20.0% | -23.9% | -21.7% | +0.0% | +0.5% | +14.1% | +24.9% | >999% | +8.0% | +1.5% | +3.3% | +0.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.